Tessera

How do blood stem cells develop in the embryo? Could this knowledge help researchers to generate blood stem cells outside the body? 🩸 Our funded researcher, Dr Samanta Mariani, reveals some fascinating insights in her latest paper. Read more: labs.sciety.org/articles/by?...

Leukaemia UK-funded researcher, Dr Samanta Mariani, is wearing a lab coat and preparing to use a microscope. The text reads, 'New paper: Understanding how blood stem cells first develop during the embryonic stages'.

We're proud to be supporting the MyeCare UK AML registry, bringing together experts from across the haematology community to create a richer understanding of AML and improve outcomes for patients. 🧡

A healthcare worker wearing a blue uniform with a stethoscope around their neck. They are holding a patient’s hand compassionately. The text reads, ‘We’re pleased to be supporting the MyeCare UK AML registry’.

Mednet @mednethealth.bsky.social · last mo.

We’re delighted that thousands more people, including those with leukaemia, will now be eligible for the RSV vaccine on the NHS. 💉 We called for broader access to RSV vaccination for people at increased risk and are pleased to see this reflected. 👏 www.england.nhs.uk/2026/07/thou...

Earlier this week some of our team travelled into London to join @leukaemiauk.bsky.social for their #CartwheelForACure event. It was great to have been invited. We look forward to working with the Leukaemia UK team again in the future. #LeukaemiaAwareness

Researchers have shown that CAR-T cell therapy could target the cells driving myeloproliferative neoplasms (MPNs) - blood cancers that can progress to acute leukaemia. 🩸 Another exciting step towards expanding where CAR-T therapies can make a difference. 👏 www.eurekalert.org/news-release...

CAR T cell therapy targets key mutation driving rare blood cancers

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leavin...

eurekalert.org

📢 Today, NICE has recommended Pirtobrutinib for eligible people with chronic lymphocytic leukaemia (CLL) on the NHS in England. This provides another targeted treatment option for people whose CLL has returned or stopped responding after treatment with a BTK inhibitor. 👏

An orange graphic which reads, ‘New treatment for chronic lymphocytic leukaemia in England: Pirtobrutinib’ followed by ‘Approved’ with a green tick symbol.

Yesterday in Parliament, we launched our new report to end the delays in leukaemia diagnosis. Huge thanks to our sponsor Paul Holmes MP, to @douglasmcallister.bsky.social, Stuart Andrew MP and our Community Champion, Jade, for their powerful speeches, and to the 26 MPs & Peers who attended. (1/2)

Two people stand beside a Leukaemia UK banner indoors, wearing visitor lanyards and holding orange campaign signs reading “Let’s reduce emergency diagnosis” and “Count us in.”

A speaker stands at a lectern indoors addressing an audience. He is stood next to a Leukaemia UK banner that reads “Finding and funding life-changing research that matters most”.

A group of Leukaemia UK Community Champions, and CEO Fiona Hazell, pose for a photo. They are wearing visitor lanyards and stood beside a Leukaemia UK banner.

Close-up of a printed campaign leaflet on a stone surface with the text, “End the delays in leukaemia diagnosis” with a blurred image of a group outside the Houses of Parliament.

Leukaemia UK @leukaemiauk.bsky.social · 2mo ago

Thank you Martin Vickers MP for highlighting our Parliamentary Reception and our call for earlier diagnosis of leukaemia during today’s Business Statement. We appreciate your request for a Health Minister to come to the House of Commons & outline how the Government will support earlier diagnosis.

💬 Share your views and help to strengthen the voices of people affected by rare and less common cancers, including leukaemia. Fill in @cancer52org.bsky.social's patient survey and help to shape future policy work to improve diagnosis and access to treatments: www.surveymonkey.com/r/c52patient...

A graphic with an icon of a person holding a tablet in their hands and filling out an online survey. The text reads, ‘Share your views. Help to strengthen the voices of those with rare and less common* cancers'. A disclaimer at the bottom reads, ‘*All cancers other than the four most common: breast, bowel, lung and prostate.’

Leukaemia UK @leukaemiauk.bsky.social · 2mo ago

We’re proud to be one of 89 charities awarded a share of the National Institute for Health and Care Research's £37m investment into early career researchers. This will contribute to the funding of some of our John Goldman Fellowships, which help our researchers at a crucial stage in their careers.

Association of Medical Research Charities@amrc-uk.bsky.social · 2mo ago

We’re proud to see the NIHR invest £37m across 89 medical research charities, supporting more than 800 early-career researchers. This investment recognises the vital role charities play in igniting research careers, building capacity and sustaining the talent pipeline. Read more: bit.ly/4aft801

A young researcher wearing a white lab coat and blue gloves looks through a microscope in a laboratory, with sample tubes visible in the foreground. On the right, a blue panel reads “Supporting the next generation of researchers” and highlights three statistics: £37 million NIHR funding, 89 charities, and more than 800 early career researchers, accompanied by icons of coins, a hand holding a heart, and a group of researchers.

Prof David Vetrie and team have identified two “routes” (TR1 & TR2) leading to CML - helping explain differences in patient outcomes. 💡 Now, with a second Project Grant, the team is building on this to develop more targeted therapies. 🧡 Read more: www.leukaemiauk.org.uk/the-road-to-...

For many people with leukaemia, a diagnosis comes after months or even years of not being taken seriously by healthcare professionals.‼️ Tell the Government to end the delays in leukaemia diagnosis. For people like Jade, who have to fight to be heard: action.leukaemiauk.org.uk/end-the-delay

A quote on an orange background which reads, “Relief is not the primary emotion you would expect following a leukaemia diagnosis. But for me, it was. Relief that I was finally being taken seriously and being cared for” followed by ‘Jade, leukaemia patient’.

A woman is laying in bed and holding a light brown coloured dog in her arms. She is smiling at the camera, while the dog looks away.

We are delighted to announce further funding for ground-breaking research through our 2026 Project Grants. 🔬 Applications are now open and will close at midday on 8th July 2026. Find out more and apply here 👉 leukaemiauk.org.uk/research-and-advocacy/research-funding-opportunities/project-grants

An image of a scientist working in a lab. He is using a microscope and test tubes. The text reads, ‘Applications are now open for our 2026 Project Grants'.

It took FOUR years and hundreds of visits to healthcare providers before Virginie was finally diagnosed with leukaemia. 🤯 Add your name and tell the Government to end the delays in leukaemia diagnosis: action.leukaemiauk.org.uk/end-the-delay

A simple full blood count would have diagnosed Mooni earlier and saved his family the horrendous torture of not knowing if he would ever wake up. Join over 7,000 people in calling for the Government to end the delays in leukaemia diagnosis 👉 action.leukaemiauk.org.uk/end-the-delay

For the first time, leukaemia has been recognised in the Government’s National Cancer Plan. That recognition matters. But action is what saves lives. Add your name and tell the Government to end the delays in leukaemia diagnosis: action.leukaemiauk.org.uk/end-the-delay #CountUsIn

Recognition matters. But action save lives. Add your name

Dr Kevin Rattigan, one of our funded researchers, has developed protein-based drugs called enzymes which can be used to starve leukaemia cells of some of the key nutrients they need to survive. 🎥 We caught up with Dr Rattigan in the lab to see how his research is going.

It shouldn’t have to take months of GP visits for leukaemia patients like Tracey to be taken seriously. But sadly, right now, this is their reality. 💔 Add your name and tell the Government to end the delays in leukaemia diagnosis: action.leukaemiauk.org.uk/end-the-delay

We were delighted to present our work on the first Best Practice Timed Pathway for blood cancers at @bsochaem.bsky.social conference. 🩸 This step-by-step guide - developed with @lymphomaaction.bsky.social @myelomauk.bsky.social and @england.nhs.uk - will improve diagnosis for blood cancer patients.

Holly McConnell, from Leukaemia UK’s Policy & Advocacy team, delivers a presentation on the Best Practice Timed Pathway for blood cancers at the British Society for Haematology conference.

Holly McConnell (far right) with Anna Grint from Lymphoma Action and Sarah Galley from Myeloma UK, at the British Society for Haematology conference.

Ian saw his GP twice but wasn’t taken seriously. He was eventually diagnosed with acute myeloid leukaemia (AML) at A&E. Like Ian, 1 in 4 people with leukaemia face delays in diagnosis. Add your name to end the delays: action.leukaemiauk.org.uk/end-the-delay #AMLWorldAwarenessDay #CountUsIn

No one should have to fight to be heard. But like Jade, 1 in 4 people with leukaemia face avoidable delays in their diagnosis. It’s time to end the delays. Add your name and call on the Government to act: action.leukaemiauk.org.uk/end-the-delay #CountUsIn

📢 A new treatment has been approved on the NHS in Scotland for chronic lymphocytic leukaemia (CLL). Acalabrutinib, in combination with Venetoclax, has been approved by NICE for adults with previously untreated CLL. We are so pleased to have supported in this process. 🧡

An orange graphic which reads, ‘New treatment for chronic lymphocytic leukaemia in Scotland: Acalabrutinib’ followed by ‘Approved’ with a green tick symbol.

📢 Have you been diagnosed with, or are you supporting someone with, acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS)? Would you be interested in taking part in a study which aims to improve access to stem cell transplants? Find out more: www.birmingham.ac.uk/research/pro...

Two blood bags hanging on a medical stand in a hospital setting with blurred surgical lights and staff in the background. The text reads, 'Fancy taking part in a study that could help to improve stem cell transplant services across the UK?'